Accumulating evidence has demonstrated that autism is often characterized by complex abnormalities such as oxidative stress, mitochondrial dysfunction, inflammation, certain genetic abnormalities, exposure(s) to environmental toxicants, immunological abnormalities, infections, and in some cases, developmental regression and seizures. These abnormalities may contribute to the symptoms of autism, such as sleep problems, obsessive behavior, speech delay, impaired social interaction, self-stimulatory behavior, hyperactivity, inattention, and abnormal gastrointestinal findings. Many children with autism have a unique combination of these abnormalities and may possess some or all of these problems simultaneously. The early identification of these abnormalities helps clinicians and parents to choose the most effective treatment options. Dr. Rossignol's aim is to identify the unique biochemical abnormalities that each individual possesses (e.g., the biochemical fingerprint) and works to create the most effective treatments for these abnormalities using evidence-based medicine principles.

Join host Alex Doman and Dr. Dan Rossignol as they discuss the latest biomedical research in the autism field, his approach toward individualized treatment, and efforts to prepare other medical professionals to deliver the best possible care to children with autism through the Medical Academy of Pediatric Special Needs (MAPS).